E. Shojaeefar, M. Ghaffari, M. Mohammadi, J. Hosseini, and M. D. Omrani, “What we Know so far about Myxovirus Resistance Protein A (MxA) as a Biomarker of Interferon-Beta Therapy in Patients with Multiple Sclerosis: a Systematic Review”, Arch Men Health, vol. 3, no. 1, p. e19, Dec. 2020.